Related Experiment Videos
[MODY in clinical practice. When and why to consider it?].
1INSERM U. 561, Hôpital Saint-Vincent-de-Paul F-75674 PARIS Cedex 14. gvelho@infobiogen.fr
Annales D'Endocrinologie
|August 12, 2003
Summary
Accurate diagnosis of Monogenic Diabetes of the Young (MODY) and its subtype is crucial for effective clinical management. Different genetic origins of MODY impact disease progression, consequences, and treatment strategies.
Area of Science:
- Endocrinology and Metabolism
- Human Genetics
- Diabetes Research
Context:
- Monogenic Diabetes of the Young (MODY) represents a significant portion of diabetes cases.
- Clinical practice requires precise diagnosis and subtyping of MODY for tailored patient care.
- Genetic heterogeneity of MODY necessitates understanding specific mutations for predicting disease course.
Purpose:
- To highlight the clinical importance of diagnosing MODY subtypes.
- To describe the characteristics and clinical consequences of genetic MODY abnormalities.
- To emphasize the two most common MODY subtypes: MODY-2 and MODY-3.
Summary:
- MODY diagnosis and subtyping are critical in clinical practice due to varying disease evolution, clinical outcomes, and treatment responses based on genetic origin.
- This review details the clinical implications of genetic abnormalities in MODY.
- Special attention is given to MODY-2 (glucokinase mutations) and MODY-3 (HNF-1α mutations), the most prevalent subtypes.
Impact:
- Improved clinical decision-making for MODY patients through precise subtyping.
- Enhanced understanding of genotype-phenotype correlations in diabetes.
- Potential for optimized therapeutic strategies based on specific MODY genetic profiles.